Press Release: Sanofi evolves its Executive Committee to support its next strategic chapter

{
  "signal_id": "3d2043c2-9a59-14b5-4893-c00e57606038",
  "signal_type": "news",
  "signal_subtype": "promotes",
  "detected_at": "2026-07-21T16:00:00+00:00",
  "company": {
    "name": "Sanofi",
    "domain": "sanofi.com"
  },
  "data": {
    "url": "https://www.globenewswire.com/news-release/2026/07/21/3330752/0/en/Press-Release-Sanofi-evolves-its-Executive-Committee-to-support-its-next-strategic-chapter.html",
    "title": "Press Release: Sanofi evolves its Executive Committee to support its next strategic chapter",
    "contact": "Olivier Charmeil",
    "excerpt": "Sanofi evolves its Executive Committee to support its next strategic chapter Paris, July 21, 2026 . Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter. Effective September 1, 2026, Sanofi's Executive Committee will comprise: Emmanuel Frenehard, Head of Digital and Audrey Duval, Head of Corporate Affairs, will continue to report directly to Belén Garijo, Sanofi’s CEO. Madeleine Roach, currently Head of Business Operations, will become President and Country Lead of Sanofi Germany, Switzerland and Austria. Her current responsibilities, which focus on optimizing enterprise business services, will be integrated into the Finance function. Finance’s expanded remit will also include Global Partnering and Business Development, helping drive a more integrated approach across Business Development and Mergers & Acquisitions. Thomas Triomphe will also assume responsibility for China, alongside his role as Executive Vice President, Vaccines. Olivier Charmeil, currently Executive Vice President, General Medicines, will transition to Strategic Projects Advisor to the CEO. Throughout his career, Olivier has helped shape the company across a succession of leadership roles...",
    "summary": "Sanofi has promoted Olivier Charmeil, currently Executive Vice President, General Medicines, to Strategic Projects Advisor to the CEO.",
    "planning": true,
    "image_url": "https://ml-eu.globenewswire.com/Resource/Download/06da731a-67a1-4258-939f-6ef0531ee3bf",
    "job_title": "Strategic Projects Advisor to the CEO",
    "confidence": 0.95,
    "published_at": "2026-07-21T16:00:00Z",
    "job_title_tags": [
      "directors"
    ],
    "article_sentence": "Olivier Charmeil, currently Executive Vice President, General Medicines, will transition to Strategic Projects Advisor to the CEO."
  }
}

curl https://signals.autobound.ai/v1/signals/3d2043c2-9a59-14b5-4893-c00e57606038 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"sanofi.com","limit":20}'